21.05.24 | Vollzeit | Bonn | Alliance Medical RP GmbHAlliance Medical RP GmbH, a pharmaceutical company with a team of around 30 employees at its Bonn site and around 20 employees at its Berlin site, manufactures radioactive drugs for nuclear medicine diagnostics using positron emission tomography. As a subsidiary of Alliance Medical GmbH, which
Später ansehen25.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNELateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring of disease progression
Später ansehen25.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNELateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring of disease progression
Später ansehen25.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNELateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring of disease progression
Später ansehen22.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNEFTD) and Amyotrophic Lateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring
Später ansehen22.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNEFTD) and Amyotrophic Lateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring
Später ansehen22.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNEFTD) and Amyotrophic Lateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring
Später ansehen22.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNEFTD) and Amyotrophic Lateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring
Später ansehen22.05.24 | Vollzeit | Bonn | Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. DZNEFTD) and Amyotrophic Lateral Sclerosis (ALS) (Chatterjee et al., Nat. Med., accepted). In follow-up projects, we will focus on discovery, validation, and implementation of EV-based biomarkers in different neurodegenerative diseases, covering aspects of early preclinical diagnosis, staging, monitoring
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Diagnose in Bonn kostenlos abonnieren.